Thomas E Bonney insider trades: Novadel Pharma (NVD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 30, 2007 | NVD | ↑ Buy | 5,300 | $0.79 | $4K | Direct | Aug 31, 2007 (1d) |
| Jun 30, 2006 | NVD | ↑ Buy | 19,500 | $1.32 | $26K | Direct | Jul 5, 2006 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas E Bonney's insider trades
Thomas E Bonney is a director at Novadel Pharma (NVD). Since Jun 30, 2006, Thomas has reported 2 open-market purchases worth $30K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.